Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-004988
Filing Date
2023-03-30
Accepted
2023-03-30 07:17:19
Documents
83
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K trvn-20221231x10k.htm   iXBRL 10-K 2435519
2 EX-23.1 trvn-20221231xex23d1.htm EX-23.1 6648
3 EX-31.1 trvn-20221231xex31d1.htm EX-31.1 19791
4 EX-31.2 trvn-20221231xex31d2.htm EX-31.2 19812
5 EX-32.1 trvn-20221231xex32d1.htm EX-32.1 8407
6 EX-32.2 trvn-20221231xex32d2.htm EX-32.2 8454
7 GRAPHIC trvn-20221231x10k003.jpg GRAPHIC 39164
  Complete submission text file 0001558370-23-004988.txt   10239778

Data Files

Seq Description Document Type Size
8 EX-101.SCH trvn-20221231.xsd EX-101.SCH 67830
9 EX-101.CAL trvn-20221231_cal.xml EX-101.CAL 77069
10 EX-101.DEF trvn-20221231_def.xml EX-101.DEF 288301
11 EX-101.LAB trvn-20221231_lab.xml EX-101.LAB 641186
12 EX-101.PRE trvn-20221231_pre.xml EX-101.PRE 485442
77 EXTRACTED XBRL INSTANCE DOCUMENT trvn-20221231x10k_htm.xml XML 1774811
Mailing Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087
Business Address 955 CHESTERBROOK BOULEVARD SUITE 110 CHESTERBROOK PA 19087 6103548840
TREVENA INC (Filer) CIK: 0001429560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36193 | Film No.: 23777146
SIC: 2834 Pharmaceutical Preparations